The molecular mechanisms for the anti-tumor action of As4S4 were shown to be through the induction of apoptosis [19], [20] and/or through the redistribution of PML-RARα protein in leukemic cells from APL patients [21]. Here, RARA is linked to acute promyelocytic leukemia.